SG11202107994TA - Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors - Google Patents
Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptorsInfo
- Publication number
- SG11202107994TA SG11202107994TA SG11202107994TA SG11202107994TA SG11202107994TA SG 11202107994T A SG11202107994T A SG 11202107994TA SG 11202107994T A SG11202107994T A SG 11202107994TA SG 11202107994T A SG11202107994T A SG 11202107994TA SG 11202107994T A SG11202107994T A SG 11202107994TA
- Authority
- SG
- Singapore
- Prior art keywords
- nmda
- modulators
- glycine
- decision support
- ampa receptors
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title 2
- 102000003678 AMPA Receptors Human genes 0.000 title 1
- 108090000078 AMPA Receptors Proteins 0.000 title 1
- 239000004471 Glycine Substances 0.000 title 1
- 102000011714 Glycine Receptors Human genes 0.000 title 1
- 108010076533 Glycine Receptors Proteins 0.000 title 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 230000002974 pharmacogenomic effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/10—Boolean models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/10—Ontologies; Annotations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795710P | 2019-01-23 | 2019-01-23 | |
| US201962795705P | 2019-01-23 | 2019-01-23 | |
| PCT/US2020/014549 WO2020154362A1 (en) | 2019-01-23 | 2020-01-22 | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202107994TA true SG11202107994TA (en) | 2021-08-30 |
Family
ID=69724089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107978RA SG11202107978RA (en) | 2019-01-23 | 2020-01-22 | Methods and system for the reconstruction of drug response and disease networks and uses thereof |
| SG11202107994TA SG11202107994TA (en) | 2019-01-23 | 2020-01-22 | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202107978RA SG11202107978RA (en) | 2019-01-23 | 2020-01-22 | Methods and system for the reconstruction of drug response and disease networks and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20200234810A1 (en) |
| EP (2) | EP3915120A1 (en) |
| JP (2) | JP2022518272A (en) |
| CN (2) | CN113632174A (en) |
| AU (2) | AU2020210904A1 (en) |
| CA (2) | CA3127607A1 (en) |
| SG (2) | SG11202107978RA (en) |
| WO (2) | WO2020154362A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200357482A1 (en) * | 2019-05-06 | 2020-11-12 | MedWhatBio, Inc. | Method and system for automating curation of genetic data |
| US11741557B2 (en) * | 2020-01-01 | 2023-08-29 | Rockspoon, Inc. | Biomarker-based food item design system and method |
| US20220059204A1 (en) * | 2020-08-21 | 2022-02-24 | At&T Intellectual Property I, L.P. | System and method for secure monitoring and delivery of medications |
| CN112382385A (en) * | 2020-11-12 | 2021-02-19 | 山东中医药大学 | Aura-free migraine auxiliary diagnosis algorithm based on 3D convolutional neural network |
| CN114758722B (en) * | 2022-04-21 | 2024-06-28 | 湖南大学 | Gene sequence interpolation method based on generation type countermeasure network |
| CN115101120B (en) * | 2022-06-27 | 2024-04-16 | 山东大学 | Corn alternative splicing isomer function prediction system based on data fusion |
| CN116467596B (en) * | 2023-04-11 | 2024-03-26 | 广州国家现代农业产业科技创新中心 | Training method of rice grain length prediction model, morphology prediction method and apparatus |
| CN116959561B (en) * | 2023-09-21 | 2023-12-19 | 北京科技大学 | Gene interaction prediction method and device based on neural network model |
| CN117788465B (en) * | 2024-02-26 | 2024-05-28 | 中日友好医院(中日友好临床医学研究所) | Method and device for associating local cerebral blood flow graph with transcription and cell characteristics |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002055995A2 (en) | 2001-01-10 | 2002-07-18 | Penn State Res Found | Method and system for modeling cellular metabolism |
| US7585680B2 (en) * | 2003-08-28 | 2009-09-08 | Marshfield Medical Research And Education Foundation | Method and device for monitoring medication usage |
| EP2422000A1 (en) | 2009-04-20 | 2012-02-29 | Fox Chase Cancer Center | Rotamer libraries and methods of use thereof |
| WO2012021899A2 (en) * | 2010-08-13 | 2012-02-16 | Intellimedicine, Inc. | System and methods for the production of personalized drug products |
| EP2608122A1 (en) | 2011-12-22 | 2013-06-26 | Philip Morris Products S.A. | Systems and methods for quantifying the impact of biological perturbations |
| EA201492178A1 (en) | 2012-05-22 | 2015-12-30 | Берг Ллк | CELLULAR BASED CROSS ANALYSIS FOR IDENTIFICATION OF MARKERS INDUCED BY TOXICITY MEDICINES |
| US20140274764A1 (en) * | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| JP6545788B2 (en) * | 2014-08-13 | 2019-07-17 | ヤンセン ファーマシューティカ エヌ．ベー． | How to treat depression |
| US10249389B2 (en) | 2017-05-12 | 2019-04-02 | The Regents Of The University Of Michigan | Individual and cohort pharmacological phenotype prediction platform |
-
2020
- 2020-01-22 AU AU2020210904A patent/AU2020210904A1/en active Pending
- 2020-01-22 SG SG11202107978RA patent/SG11202107978RA/en unknown
- 2020-01-22 WO PCT/US2020/014549 patent/WO2020154362A1/en active Search and Examination
- 2020-01-22 CN CN202080015844.7A patent/CN113632174A/en active Pending
- 2020-01-22 AU AU2020212972A patent/AU2020212972A1/en active Pending
- 2020-01-22 US US16/749,737 patent/US20200234810A1/en active Pending
- 2020-01-22 CA CA3127607A patent/CA3127607A1/en active Pending
- 2020-01-22 EP EP20707918.7A patent/EP3915120A1/en active Pending
- 2020-01-22 WO PCT/US2020/014536 patent/WO2020154356A1/en active Search and Examination
- 2020-01-22 US US16/749,694 patent/US11984208B2/en active Active
- 2020-01-22 CA CA3126828A patent/CA3126828A1/en active Pending
- 2020-01-22 CN CN202080015935.0A patent/CN113597645A/en active Pending
- 2020-01-22 SG SG11202107994TA patent/SG11202107994TA/en unknown
- 2020-01-22 EP EP20708286.8A patent/EP3915121A1/en active Pending
- 2020-01-22 JP JP2021542497A patent/JP2022518272A/en active Pending
- 2020-01-22 JP JP2021542448A patent/JP2022520009A/en active Pending
-
2021
- 2021-09-22 US US17/482,135 patent/US20220020466A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113597645A (en) | 2021-11-02 |
| CA3127607A1 (en) | 2020-07-30 |
| WO2020154362A1 (en) | 2020-07-30 |
| WO2020154356A1 (en) | 2020-07-30 |
| EP3915121A1 (en) | 2021-12-01 |
| SG11202107978RA (en) | 2021-08-30 |
| EP3915120A1 (en) | 2021-12-01 |
| AU2020212972A1 (en) | 2021-08-05 |
| US20200294623A1 (en) | 2020-09-17 |
| JP2022520009A (en) | 2022-03-28 |
| US11984208B2 (en) | 2024-05-14 |
| JP2022518272A (en) | 2022-03-14 |
| US20220020466A1 (en) | 2022-01-20 |
| CA3126828A1 (en) | 2020-07-30 |
| CN113632174A (en) | 2021-11-09 |
| AU2020210904A1 (en) | 2021-08-05 |
| US20200234810A1 (en) | 2020-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202107994TA (en) | Pharmacogenomic decision support for modulators of the nmda, glycine, and ampa receptors | |
| IL276332A (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| IL276330A (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| EP4084690A4 (en) | Integrated closed-loop artificial pancreas | |
| EP4076423A4 (en) | Trpml modulators | |
| GB202117674D0 (en) | Personal-public service set identifiers | |
| EP3949591A4 (en) | Bandwidth part specific scheduling configuration | |
| EP3773658A4 (en) | Kir3dl3 as an hhla2 receptor, anti-hhla2 antibodies, and uses thereof | |
| EP3864539A4 (en) | Secure service interaction | |
| EP3752197A4 (en) | Nkg2d chimeric antigen receptors | |
| EP3724220A4 (en) | Nkg2d daric receptors | |
| EP3973681A4 (en) | Secure web application delivery platform | |
| EP3911355A4 (en) | Recombinant lubricins, and compositions and methods for using the same | |
| EP4018776A4 (en) | Schedule gap for multi-sim user equipment | |
| GB201901640D0 (en) | Antibodies against hepcr | |
| EP3955742A4 (en) | Neurogenesis | |
| ZA202101523B (en) | Human pd-l1 antibodies | |
| EP3986339A4 (en) | Air hammock for a prosthetic | |
| EP3851448A4 (en) | Anti-erythropoietin receptor peptide | |
| IL289575A (en) | Modulators of the nmda receptor | |
| EP3755267A4 (en) | Extracts for the regeneration of ligaments | |
| EP3750879A4 (en) | Prostacyclin receptor agonist | |
| EP4003337A4 (en) | Aryl hydrocarbon receptor activators | |
| EP4036449A4 (en) | Screw-threaded joint | |
| EP4007574A4 (en) | Methods of treating disorders associated with elevated levels of antibodies that interact with the nmda receptor |